HOPE-3: Statin therapy works in everybody with intermediate-risk
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Subodh Verma, MD, PhD
Francesco Cosentino, MD, PhD
- Hyperlipidemia
Phase 3 study results of plozasiran in patients with FCS
Gerald F. Watts, DSc, DM, PhD
- ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
Deepak Bhatt, MD
- ESC Congress 2024
Lp(a) in patients with recent CHD
Prof. Kausik Ray, MBChB, MD, MPhil